Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
83
0.940
Why?
Bone Neoplasms
2
2023
193
0.870
Why?
Phenylthiohydantoin
1
2016
3
0.580
Why?
Warfarin
1
2016
87
0.530
Why?
Thrombosis
1
2016
243
0.460
Why?
Anticoagulants
1
2016
270
0.460
Why?
Ketoconazole
1
2010
17
0.390
Why?
Androgen Antagonists
1
2010
15
0.380
Why?
Proton Pump Inhibitors
1
2010
84
0.360
Why?
Carcinoma, Renal Cell
1
2011
120
0.360
Why?
Sulfonamides
1
2011
146
0.360
Why?
Pyrimidines
1
2011
196
0.350
Why?
Protein Kinase Inhibitors
1
2011
216
0.340
Why?
Kidney Neoplasms
1
2011
196
0.340
Why?
Antineoplastic Agents
1
2016
1300
0.300
Why?
Prostatic Neoplasms
1
2010
415
0.290
Why?
Drug Interactions
2
2016
206
0.230
Why?
Phthalazines
1
2022
19
0.210
Why?
Piperazines
1
2022
116
0.200
Why?
Indoles
1
2022
289
0.170
Why?
Retrospective Studies
3
2023
6432
0.150
Why?
Prospective Studies
1
2023
2604
0.140
Why?
Benzamides
1
2016
54
0.140
Why?
Nitriles
1
2016
69
0.140
Why?
Humans
6
2023
54284
0.130
Why?
Male
4
2022
27334
0.110
Why?
Controlled Clinical Trials as Topic
1
2011
21
0.100
Why?
Clinical Trials, Phase III as Topic
1
2011
48
0.100
Why?
Indazoles
1
2011
55
0.100
Why?
Drug Resistance
1
2010
74
0.090
Why?
Prostate-Specific Antigen
1
2010
55
0.090
Why?
Diphosphonates
1
2011
96
0.090
Why?
Imidazoles
1
2011
142
0.090
Why?
Treatment Outcome
2
2011
5604
0.090
Why?
Middle Aged
3
2016
13088
0.090
Why?
Disease-Free Survival
1
2010
485
0.090
Why?
Gastrointestinal Diseases
1
2010
126
0.090
Why?
Drug Therapy, Combination
1
2010
426
0.090
Why?
Acute Kidney Injury
1
2011
403
0.070
Why?
Aged, 80 and over
2
2011
3431
0.070
Why?
Aged
2
2011
10054
0.040
Why?
Animals
1
2011
14385
0.030
Why?
Creatinine
1
2011
169
0.020
Why?
Incidence
1
2011
1082
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1476
0.020
Why?
Time Factors
1
2011
3213
0.010
Why?
Neoplasms
1
2011
1316
0.010
Why?
Adult
1
2011
14207
0.010
Why?
Female
1
2011
28441
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description